Element 25 Limited

Element 25 Limited's next confirmed earnings release is scheduled for March 18, 2027.

As of June 30, 2024, Element 25 Limited has 219.53M shares outstanding.

As of June 30, 2024, Element 25 Limited maintains a current ratio of 3.20, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.32, indicating conservative leverage, while an interest coverage ratio of -306.81 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2024, Element 25 Limited posted a negative return on equity (ROE) of -38.23, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -32.29, reflecting losses generated across the asset base. Inventory turnover of 2.90 indicates how many times Element 25 Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2024, Element 25 Limited recorded 117.05 in income tax expense. The company reported a pretax loss of -13.40M and -13.40M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

These figures are as of the close on October 22, 2026. The 50-day moving average sits at 0.15, while the 200-day moving average is 0.17.

Over the twelve months ended June 30, 2024, Element 25 Limited generated 8.28M in revenue and converted that into -13.40M in net income, yielding earnings per share of -0.06. EBITDA reached -12.23M, while operating income came in at -13.69M.

As of June 30, 2024, Element 25 Limited holds 7.20M in cash and equivalents against 112,083.45 in total debt, resulting in a net debt position of -7.05M. Total book value stands at 35.57M, with working capital of 8.71M providing operational flexibility.

These figures cover the twelve months ended June 30, 2024.

Over the twelve months ended June 30, 2024, Element 25 Limited posted a gross margin of -118.70, reflecting its pricing power and cost economics. The operating margin of -165.38 and net profit margin of -161.80 provide insight into operational efficiency.